The Declaration of Competing Interest statements were not included in the published version of articles that appeared in the Volumes 20 and 21 of the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. For the below articles, the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Validity of a CB-NAAT assay in diagnosing Tuberculosis in comparison to culture: A study from an urban area of South India (Volume 21C, December 2020).
Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease (Volume 20C, August 2020).
Quality Improvement and Healthcare: The Mayo Clinic Quality Academy Experience (Volume 20C, August 2020).
Clinical efficacy of Vitamin D supplementation on pulmonary TB patients: the evidence of clinical trials (Volume 20C, August 2020).
Understanding the Gaps in DR-TB Care Cascade in Nigeria: a sequential mixed-method study (Volume 21C, December 2020).
TB and COVID - Public and private health sectors adapt to a new reality (Volume 21C, December 2020).
Quantitative structure-activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents (Volume 21C, December 2020).
Genexpert assay – A cutting-edge tool for rapid tissue diagnosis of tuberculous lymphadenitis (Volume 21C, December 2020).